Rocket Pharma stocks cardiac gene therapies through $53 million acquisition of Renovacor

Gene therapy developer Rocket Pharmaceuticals is on track to gain FDA approval for its pioneering program, but it’s also interested in preserving its pipeline inventory. The company agreed to Acquisition of Renovacora biotechnology working to develop a gene therapy for a form of hereditary heart failure. According to financial terms announced Tuesday, the all-share transaction … Read more

Why stock market bears are eyeing June lows after S&P 500 dips below 3900

There is something special about the 3900 level and the S&P 500. On Friday, the index finished below the crucial chart support level that has served as a battleground in recent years, leading technical analysts to warn of a possible test of stock market lows in June. “Over the past three years, at the level … Read more